The efficacy of electroacupuncture therapy for weight loss changes plasma lipoprotein A, apolipoprotein A and apolipoprotein B levels in obese women. 2008

Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
Department of Physiology, Medical Faculty, Başkent University, Ankara, Turkey. tugcab@yahoo.com

In the present study, we aimed to investigate the effects of electroacupuncture treatment on lipoprotein A, apolipoprotein A and apolipoprotein B levels in obese subjects. Fifty-eight women were studied in 3 groups as follows: 1) Placebo acupuncture (n = 15; mean age = 41.47 +/- 4.61, and mean body mass index {BMI} = 33.43 +/- 3.10); 2) Electroacupuncture (EA) (n = 20; mean age = 40.55 +/- 5.30, and BMI = 35.65 +/- 3.84) and 3) Diet restriction groups (n = 23; mean age = 42.91 +/- 4.02, and BMI = 34.78 +/- 3.29). EA was performed using the ear points, Hungry, Shen Men and Stomach the body points, Hegu (LI 4), Quchi (LI 11), Tianshu (St 25), Zusanli (St 36), Neiting (St 44) and Taichong (Liv 3) for 20 days. Intragroup comparisons were made by using paired samples t-test whereas intergroup differences were investigated by the two-way variation analysis and LSD test. There was a 4.7% (p < 0.001) weight reduction in patients with electroacupuncture application, whereas patients in diet restriction had a 2.9% (p < 0.001) weight reduction. There were significant decreases in lipoprotein A (p < 0.05) and apolipoprotein B (p < 0.05) levels in the EA compared to the control group and no changes in apolipoprotein A levels was observed in EA, diet and placebo acupuncture groups. EA therapy may be a useful approach for the treatment of obesity for both losing weight and lowing the risk factors for cardiovascular disease associated with obesity, since this application may decrease the plasma lipoprotein A and apolipoprotein B levels.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001054 Apolipoproteins A Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apo-A,ApoA
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D015431 Weight Loss Decrease in existing BODY WEIGHT. Weight Reduction,Loss, Weight,Losses, Weight,Reduction, Weight,Reductions, Weight,Weight Losses,Weight Reductions
D015669 Acupuncture Points Designated locations along nerves or organ meridians for inserting acupuncture needles. Acupoints,Acupoint,Acupuncture Point,Point, Acupuncture,Points, Acupuncture
D015671 Electroacupuncture A form of acupuncture with electrical impulses passing through the needles to stimulate NERVE TISSUE. It can be used for ANALGESIA; ANESTHESIA; REHABILITATION; and treatment for diseases.

Related Publications

Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
January 2005, The American journal of Chinese medicine,
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
August 1981, Archives of internal medicine,
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
October 2012, Obesity (Silver Spring, Md.),
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
January 1984, Arteriosclerosis (Dallas, Tex.),
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
June 2012, Journal of endocrinological investigation,
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
June 1992, Journal of internal medicine,
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
August 2002, The Journal of clinical endocrinology and metabolism,
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
December 2003, Metabolism: clinical and experimental,
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
January 2000, Indian heart journal,
Mehmet T Cabioglu, and Nimet Gündogan, and Neyhan Ergene
January 1985, Arteriosclerosis (Dallas, Tex.),
Copied contents to your clipboard!